These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 28873369)
1. Dexmedetomidine Alleviates Hyperoxia-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation. Zhang Q; Wu D; Yang Y; Liu T; Liu H Cell Physiol Biochem; 2017; 42(5):1907-1919. PubMed ID: 28873369 [TBL] [Abstract][Full Text] [Related]
2. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation. Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451 [TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381. Zhang Y; Wang X; Liu Z; Yu L J Biochem Mol Toxicol; 2018 Nov; 32(11):e22211. PubMed ID: 30102002 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway. Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats. Fu C; Dai X; Yang Y; Lin M; Cai Y; Cai S Mol Med Rep; 2017 Jan; 15(1):131-138. PubMed ID: 27959438 [TBL] [Abstract][Full Text] [Related]
6. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages. Chen Y; Huang Y; Xiong B; Luo H; Song X Gene; 2020 Oct; 758():144973. PubMed ID: 32707303 [TBL] [Abstract][Full Text] [Related]
9. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine alleviates blunt chest trauma and hemorrhagic shock‑resuscitation‑induced acute lung injury through inhibiting the NLRP3 inflammasome. Ming T; Yuan M; Kong Q; Huang Q; Xia Z; Wu X Mol Med Rep; 2020 Sep; 22(3):2507-2515. PubMed ID: 32705267 [TBL] [Abstract][Full Text] [Related]
11. [Dexmedetomidine preconditioning alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats by inhibiting NLRP3 inflammasome activation]. Han B; Chen M; Yang C; Li X Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1857-1863. PubMed ID: 35012919 [TBL] [Abstract][Full Text] [Related]
12. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways. Yang H; Lv H; Li H; Ci X; Peng L Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013 [TBL] [Abstract][Full Text] [Related]
13. Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway. Chen S; Wu Q; Zhong D; Li C; Du L Respir Res; 2020 Jun; 21(1):140. PubMed ID: 32513156 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: The TLR4/NF-κB pathway and the NLRP3 inflammasome may be involved in the mechanism. Yin D; Zhou S; Xu X; Gao W; Li F; Ma Y; Sun D; Wu Y; Guo Q; Liu H; Han L; Wang Z; Wang Y; Zhang J Brain Res; 2018 Nov; 1698():1-10. PubMed ID: 29842860 [TBL] [Abstract][Full Text] [Related]
15. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway. Lu Y; Yu T; Liu J; Gu L PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408 [TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Inhibits Parthanatos in Cardiomyocytes and in Aortic Banded Mice by the ROS-Mediated NLRP3 Inflammasome Activation. Wang L; Liu X; Zhou X; Gao F; Li X; Wang X J Cardiovasc Transl Res; 2023 Jun; 16(3):624-635. PubMed ID: 36414924 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of propofol on experimental neonatal acute lung injury. Yu X; Li C Mol Med Rep; 2019 May; 19(5):4507-4513. PubMed ID: 30942421 [TBL] [Abstract][Full Text] [Related]
18. Edaravone Attenuates the Proinflammatory Response in Amyloid-β-Treated Microglia by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion. Wang HM; Zhang T; Huang JK; Xiang JY; Chen JJ; Fu JL; Zhao YW Cell Physiol Biochem; 2017; 43(3):1113-1125. PubMed ID: 28977782 [TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine's protective mechanism against hyperoxic injury in neonatal rats. Zhang QY; Feng Y; Cai H J Physiol Pharmacol; 2024 Jun; 75(3):. PubMed ID: 39042394 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression. Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]